Steroids and/or Cytotoxic Agents Should Be Used Early in the Management of Patients with IPF -- The Pro Argument
dc.contributor.author | Sharma, Sat | |
dc.date.accessioned | 2016-06-08T18:00:06Z | |
dc.date.available | 2016-06-08T18:00:06Z | |
dc.date.issued | 2004-1-1 | |
dc.date.updated | 2016-06-07T06:59:55Z | |
dc.description.abstract | Idiopathic interstitial pneumonias comprise a heterogenous group of acute and chronic respiratory conditions. Katzenstein and Myers (1) classified these disorders according to several pathologically distinct categories: usual interstitial pneumonitis (UIP), desquamative interstitial pneumonitis ? respiratory bronchiolitis interstitial lung disease, acute interstitial pneumonitis, nonspecific interstitial pneumonitis and cryptogenic organizing pneumonitis or bronchiolitis obliterans organizing pneumonia (1). These disorders present with similar clinical features of shortness of breath, diffuse pulmonary infiltrates on chest radiograph, and histologically, a varying combination of inflammation and fibrosis. However, the natural history and response to therapy differs substantially, as some categories have more favourable prognoses than others (2). Idiopathic pulmonary fibrosis (IPF) or fibrosing alveolitis is the clinical terminology for a specific interstitial pneumonia for which the pathological process is UIP. A disorder of unknown etiology, IPF is the most common and most lethal of all interstitial pneumonias. | |
dc.description.version | Peer Reviewed | |
dc.identifier.citation | Sat Sharma, “Steroids and/or Cytotoxic Agents Should Be Used Early in the Management of Patients with IPF -- The Pro Argument,” Canadian Respiratory Journal, vol. 11, no. 3, pp. 207-209, 2004. doi:10.1155/2004/534612 | |
dc.identifier.uri | http://dx.doi.org/10.1155/2004/534612 | |
dc.identifier.uri | http://hdl.handle.net/1993/31420 | |
dc.language.rfc3066 | en | |
dc.rights | open access | en_US |
dc.rights.holder | Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.title | Steroids and/or Cytotoxic Agents Should Be Used Early in the Management of Patients with IPF -- The Pro Argument | |
dc.type | Journal Article |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.24 KB
- Format:
- Item-specific license agreed to upon submission
- Description: